Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
PwC
Biotech
Biotech IPO window will ‘gradually reopen’ in 2024: PwC
After a year when most biotechs had given up on going public, the IPO window will “gradually reopen” next year, according to analysts at PwC.
James Waldron
Dec 14, 2023 9:39am
M&A values halve, volumes plunge. Will we ever see deals again?
Dec 8, 2022 8:25am
Expect a 'buoyant year' in biopharma M&A with $1.7T to deploy
Feb 15, 2022 8:00am